Page last updated: 2024-08-25

alantolactone and Infarction, Middle Cerebral Artery

alantolactone has been researched along with Infarction, Middle Cerebral Artery in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, J; Tan, L; Tan, R; Wang, Y1

Other Studies

1 other study(ies) available for alantolactone and Infarction, Middle Cerebral Artery

ArticleYear
Anti-Neuroinflammatory Effect of Alantolactone through the Suppression of the NF-κB and MAPK Signaling Pathways.
    Cells, 2019, 07-18, Volume: 8, Issue:7

    Topics: Animals; Anti-Inflammatory Agents; Brain; Infarction, Middle Cerebral Artery; Lactones; Male; MAP Kinase Signaling System; Mice; Neuroprotective Agents; NF-kappa B; PC12 Cells; Rats; Rats, Sprague-Dawley; Sesquiterpenes, Eudesmane

2019